Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists

Article English OPEN
Guirguis, Amira ; Corkery, John ; Stair, Jacqueline ; Kirton, Stewart ; Zloh, Mire ; Goodair, Christine ; Schifano, Fabrizio ; Davidson, Colin (2015)

Purpose\ud – The purpose of this paper is to determine pharmacists’ knowledge of legal highs (novel psychoactive substances (NPS)).\ud \ud Design/methodology/approach\ud – A questionnaire was handed out at two London pharmacist continuing education events in mid-2014. These events update pharmacists about developments of interest/relevance to the profession and to improve their practice. A total of 54 forms were returned; a response rate of 26 percent.\ud \ud Findings\ud – Most pharmacists had poor knowledge of NPS and many considered that NPS were not important to their work, with few having had to advise customers in this area. Despite this, the majority thought that they had insufficient information about NPS. There was a negative correlation between the age of the pharmacist and knowledge of NPS.\ud \ud Research limitations/implications\ud – The sample is a self-selected one drawn from registered pharmacists working in community pharmacies in northwest London, and thus does not include hospital pharmacies. Self-selection means that respondents may only reflect those who are interested in the NPS phenomenon and not the wider pharmacy community. The geographical area covered may not be representative of London as a whole, or indeed other parts of the UK or other EU countries.\ud \ud Practical implications\ud – It is clear that pharmacists do not know much about NPS but would like to know more. This information might improve their practice.\ud \ud Social implications\ud – Pharmacists, easier to see than general practitioners, could be a useful source of information for NPS misusers.\ud \ud Originality/value\ud – There have been no previous attempts to gauge the level of knowledge by pharmacists of legal highs/NPS in the UK or elsewhere to our knowledge.
  • References (16)
    16 references, page 1 of 2

    1. Schifano F (2015) Novel Psychoactive substances (NPS): clinical and pharmacological issues. Drugs and Alcohol Today 15 (1) 21-27.

    2. Papaseit E, Farre M, Schifano F, Torrens M (2014) Emerging drugs in Europe. Curr. Opin. Psychiatry 27 (4) 243-50.

    3. King LA, Nutt DJ. Deaths from “legal highs”: a problem of definitions. The Lancet 2014; 383: 952.

    4. EMCDDA. (2011). Responding to new psychoactive substances. Drugs in focus No 22. December. Lisbon: European Monitoring Centre for Drugs & Drug Addiction. Available at:

    5. Deluca P, Davey Z, Corazza O, Di Furia, Farre M, Flesland LH, Mannonen M, Majava A, Peltoniemi T, Pasinetti M, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog Neuro-Psychopharmacol & Biol Psychiatry 2012; 39: 221-226

    6. Corkery J, Claridge H, Loi B, Goodair C, Schifano F. Drug-related deaths in the UK: Annual Report 2013. International Centre for Drug Policy, St George's University of London. Available at:

    7. Hale KM, Murawski MM, Huerta J. Pharmacist roles in combating prescription drug abuse. J Am Pharm Assoc 2009; 49: 589-92.

    8. Future Pharmacists, Standards for the initial training of pharmacists. General Pharmaceutical Council (2011). Accessed on 20/04/2015 from

    9. Wragg, K. Substance use and misuse. 2010. The Centre for Pharmacy Postgraduate Education (CPPE), University of Manchester: HMSO. Accessed on 20/04/2015 from

    11. Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern? CNS Drugs 2014; 28: 491-496.

  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Central Lancashire Online Knowledge - IRUS-UK 0 33
Share - Bookmark